Tech Company Financing Transactions
VedaBio Funding Round
VedaBio, based in Champaign, secured $40 million in investment from OMX Ventures and Kleinmuntz Associates.
Transaction Overview
Company Name
Announced On
10/17/2023
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Undisclosed
Investors
OMX Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand operations, R&D sector and its business reach.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
60 Hazelwood Drive
Champaign, IL 61820
USA
Champaign, IL 61820
USA
Phone
Website
Email Address
Overview
VedaBio is unlocking a universe of possibilities in molecular biology with a breakthrough platform for near-instant molecular detection of highly multiplexed analytes, delivering best-in-class accuracy without the need for target amplification.
Management Team
Browse more venture capital transactions:
Prev: 10/17/2023: Hiive venture capital transaction
Next: 10/17/2023: Zelus Analytics venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs